Purpura fulminans-a rare complication post COVID-19 infection in children

Authors

  • Rochelle A. Pereira Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal University, Manipal, Karnataka, India
  • Suneel C. Mundkur Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal University, Manipal, Karnataka, India
  • Akshaya Neminathan Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal University, Manipal, Karnataka, India
  • Karen J. Moras Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal University, Manipal, Karnataka, India
  • Divya Mary George Department of Paediatrics, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal University, Manipal, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20232258

Keywords:

Children, Purpura fulminans, Post COVID-19 infection

Abstract

Coronavirus disease 2019 (COVID-19) was officially declared as a pandemic in March 2020. COVID-19 infection and the post infectious sequalae has been widely researched since then. Post infectious inflammatory sequalae and its associated complications like toxic shock syndrome, Kawasaki like disease, macrophage activation syndrome, rather than the infection per se was found to be more of a concern in children, leading to more morbidity and mortality. Purpura fulminans was not a presentation reported post COVID-19 infection. Herein, we aim to describe a post COVID-19 infection patient who presented with purpura fulminans as a rare complication.

References

Tape C, Byrd KM, Aung S, Lonks JR, Flanigan TP, Rybak NR. COVID-19 in a Patient Presenting with Syncope and a Normal Chest X-ray. R I Med J. 2020;103(3):50-1.

Bose S, Adapa S, Konala VM, Gopalreddy H, Sohail S, Naramala S et al. Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient. J Investig Med High Impact Case Rep. 2020;8:2324709620931240.

Rismanbaf A. Potential Treatments for COVID-19; a Narrative Literature Review. Arch Acad Emerg Med. 2020;8(1):e29.

Esposito S, Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr Drugs 2021;23(2):119-29.

Adcock DM, Brozna J, Marlar RA. Proposed classification and pathologic mechanisms of Purpura fulminans and skin necrosis. Semin Thromb Hemostat. 1990;16:333-40.

Herrera R, Hobar PC, Ginsburg CM. Surgical intervention for the complications of meningococcal-induced purpura fulminans. Pediatr Infect Dis J. 1994;13:734-37.

Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medical management. Ped Dermatol. 1998;15:169-83.

Shah S, Fite LP, Lane N, Parekh P. Purpura fulminans associated with acute West Nile virus encephalitis. J Clin Virol. 2016;75:1-4.

Downloads

Published

2023-07-27

Issue

Vol. 10 No. 8 (2023): August 2023

Section

Case Reports